.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Covington
Citi
Fuji
QuintilesIMS
Argus Health
Teva
Cantor Fitzgerald
Boehringer Ingelheim
Merck

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019044

« Back to Dashboard

NDA 019044 describes INDIUM IN 111 OXYQUINOLINE, which is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. Additional details are available on the INDIUM IN 111 OXYQUINOLINE profile page.

The generic ingredient in INDIUM IN 111 OXYQUINOLINE is indium in-111 oxyquinoline. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indium in-111 oxyquinoline profile page.

Summary for 019044

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 019044

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INDIUM IN 111 OXYQUINOLINE indium in-111 oxyquinoline INJECTABLE;INJECTION 019044 NDA Medi-Physics Inc. dba GE Healthcare. 17156-021 17156-021-01 1 VIAL in 1 BOX (17156-021-01) > 1 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1mCi/ML
Approval Date:Dec 24, 1985TE:RLD:Yes

Expired Orange Book Patents for NDA: 019044

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge HealthcareINDIUM IN 111 OXYQUINOLINEindium in-111 oxyquinolineINJECTABLE;INJECTION019044-001Dec 24, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Teva
US Department of Justice
McKinsey
Harvard Business School
Colorcon
Boehringer Ingelheim
Baxter
UBS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot